Now Reading: Maharashtra FDA cancels InduCare Pharma license over contaminated drugs
-
01
Maharashtra FDA cancels InduCare Pharma license over contaminated drugs
Maharashtra FDA cancels InduCare Pharma license over contaminated drugs
The Maharashtra Food and Drug Administration on August 6 permanently cancelled the manufacturing licence of Pune-based InduCare Pharma Pvt. Ltd. after six Ayurvedic medicines failed quality tests. Samples of Sinhanad Guggul and…
The Story in Brief
The Maharashtra Food and Drug Administration on August 6 permanently cancelled the manufacturing licence of Pune-based InduCare Pharma Pvt. Ltd. after six Ayurvedic medicines failed quality tests. Samples of Sinhanad Guggul and Punarnavadi Mandur had fungal growth. Hingvastak Churna and Triphala Churna contained insects, larvae, and other foreign impurities. Triphala Guggul and Kanchanar Guggul exceeded microbial limits. A joint inspection found incomplete batch records, missing ingredients, poor sanitation, damaged equipment, and no pest-control documentation. The FDA said the company violated the Drugs and Cosmetics Act and Good Manufacturing Practice norms. Commissioner Tukaram Mundhe said strict action will be taken against any manufacturer showing negligence on drug quality.
The Indian Opinion
This case will fuel the old debate: is Ayurveda inherently unsafe? That is the wrong question. The fault here is not with the system of medicine but with a manufacturer who skipped ingredients, ignored hygiene, and kept no records, exactly what the Drugs and Cosmetics Act forbids. The FDA has shown that enforcement works, but only when it is consistent. The real test is whether the Maharashtra FDA will inspect every Ayurvedic unit with the same rigour, not just during a campaign, and whether the results will be made public.
Source: thehindu.com
This story was synthesised by AI from the source linked above.
